MyAverix Finance
SA · Healthcare
Regeneron Pharmaceuticals, Inc. (REGN34)
Biotechnology
Regeneron Pharmaceuticals, Inc. (REGN34) is listed on SA in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for REGN34
Regeneron Pharmaceuticals, Inc. (REGN34) — FAQ
What is REGN34's P/E ratio?
The price-to-earnings (P/E) ratio for Regeneron Pharmaceuticals, Inc. (REGN34) is 25.00 (data as of 2026-05-23).
Does Regeneron Pharmaceuticals, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Regeneron Pharmaceuticals, Inc. (REGN34). Check the MyAverix Finance app for the latest dividend data.
What sector is Regeneron Pharmaceuticals, Inc. in?
Regeneron Pharmaceuticals, Inc. (REGN34) is classified in the Healthcare sector (Biotechnology industry).
What exchange is REGN34 listed on?
REGN34 is listed on SA.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.